Vivo Capital, LLC Aclaris Therapeutics, Inc. Transaction History

Vivo Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $217,698 - $400,529	-22,351 Reduced 2.43%	898,631 $15.5 Million
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $242,602 - $365,584	-19,772 Reduced 2.1%	920,982 $13.4 Million
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $5.8 Million - $8.15 Million	-433,525 Reduced 31.55%	940,754 $16.9 Million
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $4.66 Million - $8.08 Million	-272,935 Reduced 16.57%	1,374,279 $24.1 Million
Q1 2020 May 15, 2020	BUY	$0.75 - $2.18 $1.24 Million - $3.59 Million	1,647,214 New	1,647,214 $1.71 Million
Q3 2019 Nov 13, 2019	SELL	$0.79 - $2.47 $1.3 Million - $4.07 Million	-1,647,214 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$21.47 - $27.8 $26 Million - $33.7 Million	-1,211,355 Reduced 42.38%	1,647,214 $40.6 Million
Q3 2017 Nov 13, 2017	BUY	$23.02 - $28.8 $65.8 Million - $82.3 Million	2,858,569	2,858,569 $73.8 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.